KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Sales (2016 - 2025)

Historic Return on Sales for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.02%.

  • Biogen's Return on Sales fell 1300.0% to 0.02% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.13%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.13% for FY2025, which is 400.0% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Return on Sales is 0.02%, which was down 1300.0% from 0.18% recorded in Q3 2025.
  • Biogen's Return on Sales' 5-year high stood at 0.45% during Q3 2022, with a 5-year trough of 0.03% in Q3 2023.
  • In the last 5 years, Biogen's Return on Sales had a median value of 0.16% in 2023 and averaged 0.17%.
  • In the last 5 years, Biogen's Return on Sales skyrocketed by 3400bps in 2022 and then plummeted by -4800bps in 2023.
  • Biogen's Return on Sales (Quarter) stood at 0.01% in 2021, then surged by 1646bps to 0.22% in 2022, then tumbled by -52bps to 0.1% in 2023, then grew by 4bps to 0.11% in 2024, then crashed by -120bps to 0.02% in 2025.
  • Its Return on Sales stands at 0.02% for Q4 2025, versus 0.18% for Q3 2025 and 0.24% for Q2 2025.